Alberta Investment Management Corp (AIMCo)’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-21,257
Closed -$552K 1052
2023
Q2
$552K Buy
21,257
+8,734
+70% +$234K 0.01% 916
2023
Q1
$360K Hold
12,523
﹤0.01% 1044
2022
Q4
$371K Sell
12,523
-15,388
-55% -$438K ﹤0.01% 956
2022
Q3
$664K Hold
27,911
0.01% 1017
2022
Q2
$623K Buy
+27,911
New +$623K ﹤0.01% 1014
2020
Q4
Sell
-5,700
Closed -$202K 856
2020
Q3
$202K Sell
5,700
-19,900
-78% -$719K ﹤0.01% 924
2020
Q2
$966K Sell
25,600
-1,700
-6% -$56K 0.01% 667
2020
Q1
$789K Buy
27,300
+11,800
+76% +$477K 0.01% 625
2019
Q4
$804K Sell
15,500
-4,600
-23% -$267K 0.01% 714
2019
Q3
$1.1M Buy
20,100
+12,100
+151% +$621K 0.01% 620
2019
Q2
$325K Buy
+8,000
New +$292K ﹤0.01% 822
2019
Q1
Sell
-21,200
Closed -$713K 897
2018
Q4
$713K Buy
+21,200
New +$765K 0.01% 627
2014
Q2
Sell
-184,507
Closed -$7.58M 474
2014
Q1
$7.58M Buy
+184,507
New +$6.86M 0.09% 306

Other funds holding ANIK

Alberta Investment Management Corp (AIMCo)'s ANIK Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Anika Therapeutics (ANIK) in Q3 2023, closing a stake of 21,257 shares — an estimated $552K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ANIK in Q1 2014 and held it in 13 quarters. The position peaked at $7.58M in Q1 2014. 116 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Anika Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 21,257 Anika Therapeutics shares in Q3 2023, an estimated $552K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Anika Therapeutics in Q1 2014 and held it in 13 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Anika Therapeutics position peaked at $7.58M in Q1 2014.
  • 116 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.